Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
NANOBAC PHARM (NNBP) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.01M |
|
$-6.57M |
|
$0.01M |
|
-- |
|
$4.91M |
|
$-4.90M |
|
$-1.65M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-4.90M |
|
$-4.44M |
|
233.81M |
|
-- |
|
$-0.03 |
|
-- |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.03M |
|
$7.18M |
|
$7.22M |
|
$6.74M |
|
-- |
|
$2.83M |
|
$9.58M |
|
$-2.36M |
|
$-9.50M |
|
$-2.36M |
|
-- |
|
| Cash Flow Statement Financials | |
$-0.91M |
|
$0.04M |
|
$0.91M |
|
$0.04M |
|
$0.00M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-1.75 |
|
30.00% |
|
-49000.00% |
|
-49000.00% |
|
-44400.00% |
|
-65700.01% |
|
-65700.01% |
|
$-0.91M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.00 |
|
5.00 |
|
73.00 |
|
278.39% |
|
69.16% |
|
-91.00% |
|
278.39% |
|
-- |
|
-- |
|
-- |
|